AMAG Pharmaceuticals CEO William Heiden's 2019 pay slips 2% to $4.9M
AMAG Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
AMAG Pharmaceuticals reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, five executives at AMAG Pharmaceuticals received on average a compensation package of $2.1M, a 6% decrease compared to previous year.
Average pay of disclosed executives at AMAG Pharmaceuticals
William K. Heiden, Chief Executive Officer, received $4.9M in total, which decreased by 2% compared to 2018. 63% of Heiden's compensation, or $3M, was in stock awards. Heiden also received $474K in non-equity incentive plan, $547K in option awards, $791K in salary, as well as $11K in other compensation.
For fiscal year 2019, the median employee pay was $189,221 at AMAG Pharmaceuticals. Therefore, the ratio of William K. Heiden's pay to the median employee pay was 26 to one.
Edward Myles, Chief Financial Officer, received a compensation package of $1.4M, which decreased by 6% compared to previous year. 40% of the compensation package, or $575K, was in stock awards.
Joseph D. Vittiglio, General Counsel, earned $1.4M in 2019, a 5% decrease compared to previous year.
Anthony Casciano, Chief Commercial Officer, received $1.4M in 2019.
Julie Krop, Chief Medical Officer, earned $1.3M in 2019, a 19% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2020.